Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis
ConclusionRapid-acting insulin analogs appear generally safe and effective in these special populations; however, additional trials would be helpful.FundingNovo Nordisk A/S.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Children | Diabetes | Diabetes Type 1 | Endocrinology | Humalog | Insulin | Pediatrics | Pregnancy | Study | Women